Review



cck8 working solution (10 µl cck-8 jo ur na l p re -p ro of reagent for each well)  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Thermo Fisher cck8 working solution (10 µl cck-8 jo ur na l p re -p ro of reagent for each well)
    Cck8 Working Solution (10 µl Cck 8 Jo Ur Na L P Re P Ro Of Reagent For Each Well), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cck8+working+solution/pm39608596-112-9-36
    Average 90 stars, based on 1 article reviews
    cck8 working solution (10 µl cck-8 jo ur na l p re -p ro of reagent for each well) - by Bioz Stars, 2026-11
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: Scutellarin combined with lidocaine exerts antineoplastic effect in human glioma associated with repression of epidermal growth factor receptor signaling.
    Article Snippet: For 48 h of intervention, 10 μl of CCK-8 reagent was added into each well and incubated at 37 ̊C for 4 h. The absorbance (OD value) was acquired by Multiskan Spectrum Microplate Spectrophotometer (Thermo, USA) at a wavelength of 450 nm.

    Article Title: Mesenchymal Stem Cells With Polydopamine-Coated NaGdF 4 Nanoparticles with Ca 2+ Chelation Ability for Ischemic Stroke Therapy.
    Article Snippet: Mesenchymal stem cells (MSCs) transplantation is a promising therapeutic strategy for ischemic stroke.. However, the survival of transplanted MSCs is often compromised by the excessive levels of reactive oxygen species (ROS) and calcium ions (Ca2+) in the ischemic microenvironment following blood flow occlusion.. In this study, a protective strategy is developed using functional nanomaterials to escort and shield MSCs.

    Article Title: High-affinity uric acid clearance based on motile β-CD/F-127 polyrotaxane microspheres for enhanced diabetic wound repair
    Article Snippet: Hyperuricemia-related diabetic wounds are notoriously difficult to treat due to elevated uric acid (UA) levels, excessive reactive oxygen species (ROS), and chronic inflammation.. Current therapies often fail to address these underlying causes, underscoring the need for innovative approaches that not only clear UA but also mitigate inflammation and promote tissue regeneration.. In this study, we developed a polyrotaxane-based microsphere (HPR MS) system conjugated with 4,5-diamino-2-thiouracil (DT) to achieve high-affinity UA clearance without increasing cytotoxicity.

    Article Title: Octyl succinic anhydride-modified chitosan/oxidized sodium alginate Schiff base hydrogel loaded with terbinafine hydrochloride: pH-responsive, self-repairing, antifungal properties.
    Article Snippet: The application of hydrogels to drug delivery limited by the difficulty of encapsulating hydrophobic drugs; therefore, the development of novel composite hydrogels for the delivery of hydrophobic drugs is urgently needed.. In this study, terbinafine hydrochloride/hydroxypropyl-β-cyclodextrin inclusion complexes (TFH/HPβ-CD ICs) were added to a Schiff base hydrogel matrix containing octenyl succinic anhydride-modified chitosan (OSA-CS) and sodium alginate (OIA) to prepare a TFH composite hydrogel (TFH GEL).. The results revealed that the solubility of TFH in water within TFH/HP-β-CD IC reached 32.13 mg/mL.

    Article Title: Comprehensive analysis reveals the tumor suppressor role of macrophage signature gene FCER1G in hepatocellular carcinoma
    Article Snippet: Si-NC or si-FCER1G cells were seeded into 96-well plates at a density of 2 × 10^4 cells per well and incubated for 12 h. Subsequently, 100 μL of DMEM and 10 μL of CCK-8 solution were added to each well and incubated for 1 h. Absorbance at 450 nm was measured using a microplate reader (Thermo Scientific, Waltham, MA, USA).

    Article Title: Evaluating H2BC9 as a potential diagnostic and prognostic biomarker in head and neck squamous cell carcinoma
    Article Snippet: Briefly, 1 × 10 3 cells/well were seeded into a 96-well plate and cultured for 0, 24, 48, 72, and 96 h. CCK-8 solution (10 μL) was added to each well and incubated at 37 °C for 2 h. The optical density was measured at 450 nm using a microplate reader (Thermo Fisher Scientific).

    Incubation:

    Article Title: 3D-printed biomimetic scaffold with liposome-encapsulated SB431542 promotes scarless wound healing
    Article Snippet: Abnormal wound scarring often leads to functional impairments and cosmetic deformities, primarily driven by the prolonged activation of the TGFβ/Smad signaling pathway.. Addressing this challenge, we developed a biomimetic scaffold aimed at facilitating rapid and scarless wound healing.. This highly integrated 3D-printed dermal scaffold comprised modified recombinant human type III collagen (rhCOLIIIMA), gelatin methacrylate (GelMA), and liposomes encapsulating SB431542 to target TGFβ1 (Lip@SB).



    Similar Products

    99
    Dojindo Labs cck8 working solution
    Cck8 Working Solution, supplied by Dojindo Labs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cck8+working+solution/Cell+Counting+Kit-8/pmc12855196-401-5-9
    Average 99 stars, based on 1 article reviews
    cck8 working solution - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    90
    GlpBio Technology Inc cck8 working solution
    Cck8 Working Solution, supplied by GlpBio Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cck8+working+solution/cell+counting+kit+8+cck+8/pm40072654-32-2-5
    Average 90 stars, based on 1 article reviews
    cck8 working solution - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Keygen Biotech cck8 working solution cat. kga317
    Cck8 Working Solution Cat. Kga317, supplied by Keygen Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cck8+working+solution/cell+counting+kit+8+cck+8/pmc12140320-395-13-18
    Average 90 stars, based on 1 article reviews
    cck8 working solution cat. kga317 - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Abbkine Inc cck8 working solution bmu106-cn
    Cck8 Working Solution Bmu106 Cn, supplied by Abbkine Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cck8+working+solution/cell+counting+kit+8+cck+8/pm40015203-62-40-43
    Average 90 stars, based on 1 article reviews
    cck8 working solution bmu106-cn - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher cck8 working solution
    Characterization of adipocytes and adipose-derived stem cells (ADSCs) in areas adjacent (ALFC) and distant (DLFC) to large fibrous connective tissue (LFC) (n = 5, unpaired t -test). ( A , B ) Perilipin immunofluorescence of adipose tissue after 3 days and 7 days of incubation in serum-free medium under 1% volume fraction oxygen. ( C , D ) Dedifferentiation of mature adipocytes after 14 days and 21 days of ceiling culture. ( E ) Proliferative capacity of ADSCs by <t>CCK-8</t> test. ( F , G ) Cell migration ability of ADSCs within 24 h. ( H ) Chondrogenic, osteogenic, and adipogenic differentiation potential of ADSCs under normoxic (21% O 2 ) and hypoxic (1% O 2 ) conditions. ( I ) Comparison of adipogenic area stained with Oil Red O. *, p < 0.05. ns: Not significant. Scale bar: 100 μm ( A ); 10 μm (( C ) (200×)); 20 μm (( C ) (100×)); 20 μm ( F ); 20 μm ( H ).
    Cck8 Working Solution, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cck8+working+solution/cck+8+reagent/pmc11939587-160-0-31
    Average 90 stars, based on 1 article reviews
    cck8 working solution - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    94
    MedChemExpress cck8 working solution
    Fig. 1 Fucoidan reduced FFA-induced lipid accumulation in HepG2 cells. (A) The experimental flow of FFAs stimulation and fucoidan treatment in HepG2 cells. HepG2 cells were adhered in plates and cultured for 24 h, then stimulated with FFA (0.5 mM) for 24 h, further treated with DMSO (control) or fucoi dan (1, 10, 50, 100 µg/ml) for additional 24 h. (B) Detection of fucoidan cytotoxicity in HepG2 cells. HepG2 cells were stimulated with DMSO or fucoidan (1, 10, 50, 100 µg/ml) for 24 h, then the cell viability was detected using the <t>CCK-8</t> assay. (C) Fucoidan improved FFA-induced cytotoxicity. HepG2 cells were treated as described in (A), and then the cell viability was detected using the CCK-8 assay. (D) Fucoidan decreased intracellular TG content in HepG2 cells. HepG2 cells were treated as described in (A), and then the intracellular TG content was measured. (E) Fucoidan inhibited lipid droplet formation in HepG2 cells. HepG2 cells were treated as described in (A), and then the cells were stained with oil red O. Data were analyzed by the student’s t test and expressed as the mean ± SD (n = 3). * represents the differences compared to the control group. # represents the differences compared to the DMSO group. ** P < 0.01; ##P < 0.01
    Cck8 Working Solution, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cck8+working+solution/Sincalide/pm39962463-59-27-30
    Average 94 stars, based on 1 article reviews
    cck8 working solution - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    90
    Dojindo Labs cck8 working solution (dojindo, japan)
    Elevated deoxycholic acid (DCA) levels in a mouse model of necrotizing. enterocolitis (NEC). A and B , Survival rate and weight of the mice on the final day of the modeling procedure ( A , log-rank; B , unpaired t -tests). C , Representative photomicrographs of ileum tissue from each group (n=6; magnification ×10 and 20×, with the scale bars indicating 100 and 50 µm, respectively). D , Histopathological scoring of ileum tissue in mice (on a 0-4 scale; n=6; Kruskal-Wallis test). E and F , Quantification of bile acids in serum and fecal samples (n≥4; unpaired t -tests). G , IEC-6 cells treated with DCA for 24 h, and cell proliferation assessed using the <t>CCK8</t> assay (n=3; unpaired t -tests). H and I , Migration rate of IEC-6 cells assessed by wound-healing assay after treatment with 200 µM DCA for 24 h (n=6; unpaired t -tests; scale bar indicates 100 µm). The data are reported as means±SD. *P<0.05, **P<0.01, ***P<0.001,****P<0.0001.
    Cck8 Working Solution (Dojindo, Japan), supplied by Dojindo Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cck8+working+solution/cell+counting+kit+8/pmc11653493-52-8-11
    Average 90 stars, based on 1 article reviews
    cck8 working solution (dojindo, japan) - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher cck8 working solution (10 µl cck-8 jo ur na l p re -p ro of reagent for each well)
    Elevated deoxycholic acid (DCA) levels in a mouse model of necrotizing. enterocolitis (NEC). A and B , Survival rate and weight of the mice on the final day of the modeling procedure ( A , log-rank; B , unpaired t -tests). C , Representative photomicrographs of ileum tissue from each group (n=6; magnification ×10 and 20×, with the scale bars indicating 100 and 50 µm, respectively). D , Histopathological scoring of ileum tissue in mice (on a 0-4 scale; n=6; Kruskal-Wallis test). E and F , Quantification of bile acids in serum and fecal samples (n≥4; unpaired t -tests). G , IEC-6 cells treated with DCA for 24 h, and cell proliferation assessed using the <t>CCK8</t> assay (n=3; unpaired t -tests). H and I , Migration rate of IEC-6 cells assessed by wound-healing assay after treatment with 200 µM DCA for 24 h (n=6; unpaired t -tests; scale bar indicates 100 µm). The data are reported as means±SD. *P<0.05, **P<0.01, ***P<0.001,****P<0.0001.
    Cck8 Working Solution (10 µl Cck 8 Jo Ur Na L P Re P Ro Of Reagent For Each Well), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cck8+working+solution/pm39608596-112-9-36
    Average 90 stars, based on 1 article reviews
    cck8 working solution (10 µl cck-8 jo ur na l p re -p ro of reagent for each well) - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    Image Search Results


    Characterization of adipocytes and adipose-derived stem cells (ADSCs) in areas adjacent (ALFC) and distant (DLFC) to large fibrous connective tissue (LFC) (n = 5, unpaired t -test). ( A , B ) Perilipin immunofluorescence of adipose tissue after 3 days and 7 days of incubation in serum-free medium under 1% volume fraction oxygen. ( C , D ) Dedifferentiation of mature adipocytes after 14 days and 21 days of ceiling culture. ( E ) Proliferative capacity of ADSCs by CCK-8 test. ( F , G ) Cell migration ability of ADSCs within 24 h. ( H ) Chondrogenic, osteogenic, and adipogenic differentiation potential of ADSCs under normoxic (21% O 2 ) and hypoxic (1% O 2 ) conditions. ( I ) Comparison of adipogenic area stained with Oil Red O. *, p < 0.05. ns: Not significant. Scale bar: 100 μm ( A ); 10 μm (( C ) (200×)); 20 μm (( C ) (100×)); 20 μm ( F ); 20 μm ( H ).

    Journal: Antioxidants

    Article Title: Large Fibrous Connective Tissue Reduces Oxidative Stress to Form a Living Cell Scaffold in Adipose Grafts

    doi: 10.3390/antiox14030270

    Figure Lengend Snippet: Characterization of adipocytes and adipose-derived stem cells (ADSCs) in areas adjacent (ALFC) and distant (DLFC) to large fibrous connective tissue (LFC) (n = 5, unpaired t -test). ( A , B ) Perilipin immunofluorescence of adipose tissue after 3 days and 7 days of incubation in serum-free medium under 1% volume fraction oxygen. ( C , D ) Dedifferentiation of mature adipocytes after 14 days and 21 days of ceiling culture. ( E ) Proliferative capacity of ADSCs by CCK-8 test. ( F , G ) Cell migration ability of ADSCs within 24 h. ( H ) Chondrogenic, osteogenic, and adipogenic differentiation potential of ADSCs under normoxic (21% O 2 ) and hypoxic (1% O 2 ) conditions. ( I ) Comparison of adipogenic area stained with Oil Red O. *, p < 0.05. ns: Not significant. Scale bar: 100 μm ( A ); 10 μm (( C ) (200×)); 20 μm (( C ) (100×)); 20 μm ( F ); 20 μm ( H ).

    Article Snippet: CCK8 working solution (100 μL, CCK8:DMEM = 1:9) was added and incubated at 37 °C for 2 h. The OD value at a wavelength of 450 nm was measured by ELISA (Thermo Fisher Scientific, Waltham, MA, USA).

    Techniques: Derivative Assay, Immunofluorescence, Incubation, CCK-8 Assay, Migration, Comparison, Staining

    Fig. 1 Fucoidan reduced FFA-induced lipid accumulation in HepG2 cells. (A) The experimental flow of FFAs stimulation and fucoidan treatment in HepG2 cells. HepG2 cells were adhered in plates and cultured for 24 h, then stimulated with FFA (0.5 mM) for 24 h, further treated with DMSO (control) or fucoi dan (1, 10, 50, 100 µg/ml) for additional 24 h. (B) Detection of fucoidan cytotoxicity in HepG2 cells. HepG2 cells were stimulated with DMSO or fucoidan (1, 10, 50, 100 µg/ml) for 24 h, then the cell viability was detected using the CCK-8 assay. (C) Fucoidan improved FFA-induced cytotoxicity. HepG2 cells were treated as described in (A), and then the cell viability was detected using the CCK-8 assay. (D) Fucoidan decreased intracellular TG content in HepG2 cells. HepG2 cells were treated as described in (A), and then the intracellular TG content was measured. (E) Fucoidan inhibited lipid droplet formation in HepG2 cells. HepG2 cells were treated as described in (A), and then the cells were stained with oil red O. Data were analyzed by the student’s t test and expressed as the mean ± SD (n = 3). * represents the differences compared to the control group. # represents the differences compared to the DMSO group. ** P < 0.01; ##P < 0.01

    Journal: Lipids in health and disease

    Article Title: Fucoidan ameliorates lipid accumulation, oxidative stress, and NF-κB-mediated inflammation by regulating the PI3K/AKT/Nrf2 signaling pathway in a free fatty acid-induced NAFLD spheroid model.

    doi: 10.1186/s12944-025-02483-z

    Figure Lengend Snippet: Fig. 1 Fucoidan reduced FFA-induced lipid accumulation in HepG2 cells. (A) The experimental flow of FFAs stimulation and fucoidan treatment in HepG2 cells. HepG2 cells were adhered in plates and cultured for 24 h, then stimulated with FFA (0.5 mM) for 24 h, further treated with DMSO (control) or fucoi dan (1, 10, 50, 100 µg/ml) for additional 24 h. (B) Detection of fucoidan cytotoxicity in HepG2 cells. HepG2 cells were stimulated with DMSO or fucoidan (1, 10, 50, 100 µg/ml) for 24 h, then the cell viability was detected using the CCK-8 assay. (C) Fucoidan improved FFA-induced cytotoxicity. HepG2 cells were treated as described in (A), and then the cell viability was detected using the CCK-8 assay. (D) Fucoidan decreased intracellular TG content in HepG2 cells. HepG2 cells were treated as described in (A), and then the intracellular TG content was measured. (E) Fucoidan inhibited lipid droplet formation in HepG2 cells. HepG2 cells were treated as described in (A), and then the cells were stained with oil red O. Data were analyzed by the student’s t test and expressed as the mean ± SD (n = 3). * represents the differences compared to the control group. # represents the differences compared to the DMSO group. ** P < 0.01; ##P < 0.01

    Article Snippet: HepG2 cells were cultured in a 96-well plate with complete medium and stimulated with DMSO or fucoidan (1, 10, 50, 100 μg/mL) for 24 h. After that, CCK8 working solution (MedChemExpress, USA) was added into each well and incubated at 37 °C for 30 min.

    Techniques: Cell Culture, Control, CCK-8 Assay, Staining

    Elevated deoxycholic acid (DCA) levels in a mouse model of necrotizing. enterocolitis (NEC). A and B , Survival rate and weight of the mice on the final day of the modeling procedure ( A , log-rank; B , unpaired t -tests). C , Representative photomicrographs of ileum tissue from each group (n=6; magnification ×10 and 20×, with the scale bars indicating 100 and 50 µm, respectively). D , Histopathological scoring of ileum tissue in mice (on a 0-4 scale; n=6; Kruskal-Wallis test). E and F , Quantification of bile acids in serum and fecal samples (n≥4; unpaired t -tests). G , IEC-6 cells treated with DCA for 24 h, and cell proliferation assessed using the CCK8 assay (n=3; unpaired t -tests). H and I , Migration rate of IEC-6 cells assessed by wound-healing assay after treatment with 200 µM DCA for 24 h (n=6; unpaired t -tests; scale bar indicates 100 µm). The data are reported as means±SD. *P<0.05, **P<0.01, ***P<0.001,****P<0.0001.

    Journal: Brazilian Journal of Medical and Biological Research

    Article Title: Deoxycholic acid aggravates necrotizing enterocolitis through downregulation of mesenchymal-epithelial transition factor expression

    doi: 10.1590/1414-431X2024e14046

    Figure Lengend Snippet: Elevated deoxycholic acid (DCA) levels in a mouse model of necrotizing. enterocolitis (NEC). A and B , Survival rate and weight of the mice on the final day of the modeling procedure ( A , log-rank; B , unpaired t -tests). C , Representative photomicrographs of ileum tissue from each group (n=6; magnification ×10 and 20×, with the scale bars indicating 100 and 50 µm, respectively). D , Histopathological scoring of ileum tissue in mice (on a 0-4 scale; n=6; Kruskal-Wallis test). E and F , Quantification of bile acids in serum and fecal samples (n≥4; unpaired t -tests). G , IEC-6 cells treated with DCA for 24 h, and cell proliferation assessed using the CCK8 assay (n=3; unpaired t -tests). H and I , Migration rate of IEC-6 cells assessed by wound-healing assay after treatment with 200 µM DCA for 24 h (n=6; unpaired t -tests; scale bar indicates 100 µm). The data are reported as means±SD. *P<0.05, **P<0.01, ***P<0.001,****P<0.0001.

    Article Snippet: Following a 24-h incubation period, 10 μL of CCK8 working solution (Dojindo, Japan) was added to each well, followed by further incubation at 37°C for 4 h. The absorbance was then measured at 450 nm using an enzyme-linked immunosorbent assay reader (PerkinElmer, USA).

    Techniques: CCK-8 Assay, Migration, Wound Healing Assay

    Deoxycholic acid (DCA) suppressed the proliferation and migration of intestinal epithelial cells via mesenchymal-epithelial transition (MET) factor inhibition. A and B , IEC-6 cells were treated with 200 µM DCA for 24 h, followed by western blot analysis to detect MET expression. C-F , The expression levels of MET, p-STAT3, and STAT3 were measured in MET-deficient IEC-6 cells by western blot analysis. G , Proliferation rate of control and MET-deficient IEC-6 cells assessed by a CCK8 assay. H and I , The migration capacity of MET-deficient IEC-6 cells was evaluated using a wound-healing assay. Scale bar indicates 100 µm. The data are reported as means±SD (n=3). **P<0.01 and ****P<0.0001, unpaired t -tests. ns: non-significant.

    Journal: Brazilian Journal of Medical and Biological Research

    Article Title: Deoxycholic acid aggravates necrotizing enterocolitis through downregulation of mesenchymal-epithelial transition factor expression

    doi: 10.1590/1414-431X2024e14046

    Figure Lengend Snippet: Deoxycholic acid (DCA) suppressed the proliferation and migration of intestinal epithelial cells via mesenchymal-epithelial transition (MET) factor inhibition. A and B , IEC-6 cells were treated with 200 µM DCA for 24 h, followed by western blot analysis to detect MET expression. C-F , The expression levels of MET, p-STAT3, and STAT3 were measured in MET-deficient IEC-6 cells by western blot analysis. G , Proliferation rate of control and MET-deficient IEC-6 cells assessed by a CCK8 assay. H and I , The migration capacity of MET-deficient IEC-6 cells was evaluated using a wound-healing assay. Scale bar indicates 100 µm. The data are reported as means±SD (n=3). **P<0.01 and ****P<0.0001, unpaired t -tests. ns: non-significant.

    Article Snippet: Following a 24-h incubation period, 10 μL of CCK8 working solution (Dojindo, Japan) was added to each well, followed by further incubation at 37°C for 4 h. The absorbance was then measured at 450 nm using an enzyme-linked immunosorbent assay reader (PerkinElmer, USA).

    Techniques: Migration, Inhibition, Western Blot, Expressing, Control, CCK-8 Assay, Wound Healing Assay